Revvity, Inc. (NYSE:RVTY) Shares Sold by Cascade Financial Partners LLC

Cascade Financial Partners LLC decreased its stake in Revvity, Inc. (NYSE:RVTY - Free Report) by 3.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 186,671 shares of the company's stock after selling 7,594 shares during the period. Revvity accounts for about 2.7% of Cascade Financial Partners LLC's holdings, making the stock its 6th biggest holding. Cascade Financial Partners LLC owned 0.15% of Revvity worth $20,834,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also added to or reduced their stakes in the business. Assetmark Inc. lifted its holdings in shares of Revvity by 3,700.0% in the fourth quarter. Assetmark Inc. now owns 266 shares of the company's stock valued at $30,000 after purchasing an additional 259 shares in the last quarter. Gladius Capital Management LP purchased a new position in shares of Revvity in the third quarter valued at $32,000. Continuum Advisory LLC boosted its stake in Revvity by 2,972.7% during the third quarter. Continuum Advisory LLC now owns 338 shares of the company's stock valued at $43,000 after buying an additional 327 shares during the period. MassMutual Private Wealth & Trust FSB lifted its stake in Revvity by 55.9% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock worth $43,000 after purchasing an additional 138 shares during the last quarter. Finally, Avior Wealth Management LLC lifted its stake in Revvity by 7,980.0% during the third quarter. Avior Wealth Management LLC now owns 404 shares of the company's stock worth $52,000 after purchasing an additional 399 shares during the last quarter. Institutional investors and hedge funds own 86.65% of the company's stock.

Analysts Set New Price Targets

RVTY has been the subject of several analyst reports. Barclays increased their target price on Revvity from $135.00 to $140.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Raymond James reaffirmed an "outperform" rating and set a $145.00 price objective (up previously from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Sanford C. Bernstein downgraded Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 target price on the stock. in a research note on Friday, January 10th. Bank of America upgraded Revvity from a "neutral" rating to a "buy" rating and set a $138.00 target price on the stock in a research note on Friday, December 13th. Finally, KeyCorp raised their price target on Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. Four analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $136.25.

Remove Ads

Revvity Stock Down 4.4 %

Shares of NYSE RVTY opened at $112.97 on Wednesday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.03 and a current ratio of 3.60. The firm has a market capitalization of $13.57 billion, a price-to-earnings ratio of 51.12, a PEG ratio of 3.82 and a beta of 1.06. The stock has a 50 day moving average price of $117.07 and a 200 day moving average price of $118.14. Revvity, Inc. has a 52-week low of $97.32 and a 52-week high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same period last year, the business earned $1.25 earnings per share. Sell-side analysts expect that Revvity, Inc. will post 4.94 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be issued a $0.07 dividend. The ex-dividend date is Thursday, April 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.25%. Revvity's payout ratio is 12.67%.

Insider Activity at Revvity

In related news, insider Joel S. Goldberg sold 15,170 shares of the business's stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the transaction, the insider now owns 33,400 shares of the company's stock, valued at $4,232,782. The trade was a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Tajinder S. Vohra sold 5,492 shares of the business's stock in a transaction that occurred on Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total transaction of $641,520.52. Following the completion of the transaction, the insider now directly owns 19,652 shares of the company's stock, valued at $2,295,550.12. This trade represents a 21.84 % decrease in their position. The disclosure for this sale can be found here. 0.60% of the stock is owned by company insiders.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity, Inc. (NYSE:RVTY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.